Tag: global-footprint
-
Chiesi nears cardiovascular assets deal with Medicine Co: sources
By Carl O’Donnell and Greg Roumeliotis (Reuters) – Italian specialty pharmaceutical company Chiesi Farmaceutici SpA is close to an agreement to acquire some of Medicines Co’s cardiovascular assets for several hundred millions of dollars, according to people familiar with the matter. The transaction would allow Chiesi to expand its global footprint, while freeing up capital…
-
Gates Foundation backs Takeda polio vaccine with $38 million grant
By Kate Kelland LONDON (Reuters) – Japan’s Takeda Pharmaceuticals is to get $38 million from the Bill & Melinda Gates Foundation to develop a crucial, low-cost polio vaccine for use in developing countries. As part of a global plan to eradicate the crippling disease, of which experts say the world could see the last case…